The company’s compact spectral molecular imaging CT scanner delivers 3D colour X-rays for upper extremity imaging. Official clearance unlocks the spectral molecular imaging scanners being able to enter US medical centres and clinics for producing three-dimensional colour X-rays initially for diagnosing hand to shoulder complaints. This is the first CT imaging system developed in New Zealand to be cleared by the big agency. Chairman Chris Stoelhorst said the milestone would expand patient and clinic access to photon-counting CT imaging. The company hopes to generate sales of clinical scanners in medical centres and the likes of wrist clinics.

Source: Otago Daily Times March 29, 2026 17:03 UTC